Further to DrugAlert volume 809, HPS Pharmacies wish to advise that all suppliers are continuing to experience a supply interruption for amoxicillin + clavulanic acid 875mg/125mg tablets, as follows:

Product ARTG Estimated return date
AmoxyClav Generichealth 875/125 255076 Early March 2023
APX-Amoxicillin/Clavulanic Acid 351833 Early December 2022
APO-Amoxy/Clav 255080 End November 2022
Augmentin Duo Forte 54900 Early December 2022
Curam Duo Forte 198109 Mid-December 2022

An internationally registered brand of amoxicillin + clavulanic acid 875mg/125mg tablets has been approved for supply under Section 19A of the Therapeutic Goods Act 1989.

Oral liquids:

  • Amoxicillin 125mg/5 mL + clavulanic acid 31.25mg/5 mL powder for oral liquid (Curam® Suspension) is now also unavailable with an estimated return date of late February 2023.
  • Amoxicillin 400mg/5 mL + clavulanic acid 57 mg/5 mL powder for oral liquid is currently available.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.

Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates